Innovent Biologics, Inc. (IVBXF)
11.00
0.00 (0.00%)
USD |
OTCM |
Jan 07, 16:00
Innovent Biologics Market Cap: 18.80B for Jan. 7, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CSPC Pharmaceutical Group Ltd. | 13.23B |
| Sinovac Biotech Ltd. | 464.94M |
| China Pharma Holdings, Inc. | 4.404M |
| CASI Pharmaceuticals, Inc. | 17.75M |
| Zai Lab Ltd. | 2.108B |
Market Cap Related Metrics
| PS Ratio | 11.58 |
| Price to Free Cash Flow | 133.00 |
| Price | 11.00 |
| Earnings Yield | 0.85% |
| Operating PE Ratio | 75.21 |
| Normalized PE Ratio | 129.26 |